Respira Therapeutics, Inc.
Clinical trials sponsored by Respira Therapeutics, Inc., explained in plain language.
-
New drug shows promise for easier breathing during exercise in PAH patients
Symptom relief CompletedThis study tested a single dose of an investigational drug called RT234 in 42 adults with pulmonary arterial hypertension (PAH), a condition that makes it hard to exercise due to high blood pressure in the lungs. The main goals were to see if the drug is safe and if it improves e…
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New inhaled drug shows promise for easing lung pressure in rare Heart-Lung condition
Symptom relief CompletedThis study tested an inhaled medication called RT234 in 14 adults with pulmonary arterial hypertension (PAH), a condition where blood pressure in the lungs is dangerously high. The goal was to see if the drug could quickly lower lung blood pressure during a heart catheterization …
Phase: PHASE2 • Sponsor: Respira Therapeutics, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Inhaled ED drug tested for safety in healthy people
Knowledge-focused CompletedThis early-phase trial tested the safety and how the body processes an inhaled form of vardenafil (RT234) in 31 healthy adults. Participants received single and multiple doses of the drug via an inhaler or as a pill. The study is complete and focused on side effects and drug leve…
Phase: PHASE1 • Sponsor: Respira Therapeutics, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:51 UTC